Cadila Healthcare has informed about submission of a copy of press release dated December 5, 2019 titled ‘Zydus announces regulatory filing of Saroglitazar Magnesium for treatment of NASH with DCGI’. The contents of the press release give full details.
The above information is a part of company’s filings submitted to BSE.